DI CHIARA, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 3.230
EU - Europa 1.747
AS - Asia 403
SA - Sud America 10
AF - Africa 3
OC - Oceania 1
Totale 5.394
Nazione #
US - Stati Uniti d'America 3.220
IT - Italia 832
CN - Cina 296
FI - Finlandia 250
UA - Ucraina 207
DE - Germania 114
IE - Irlanda 106
GB - Regno Unito 81
SG - Singapore 43
SE - Svezia 29
RU - Federazione Russa 28
FR - Francia 25
BE - Belgio 20
RO - Romania 20
IN - India 16
KR - Corea 15
CA - Canada 8
IR - Iran 8
TR - Turchia 8
BR - Brasile 7
CH - Svizzera 7
NL - Olanda 7
AT - Austria 6
HK - Hong Kong 6
MK - Macedonia 6
PL - Polonia 3
LU - Lussemburgo 2
MX - Messico 2
PH - Filippine 2
ZA - Sudafrica 2
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
VN - Vietnam 1
Totale 5.394
Città #
Fairfield 456
Chandler 335
Ashburn 298
Woodbridge 261
Seattle 189
Wilmington 186
Houston 172
Ann Arbor 151
Cambridge 123
Palermo 123
Dublin 106
Jacksonville 103
Medford 88
Des Moines 82
Nanjing 63
Altamura 58
Princeton 55
Milan 49
New York 48
Lawrence 37
San Diego 36
Tulsa 30
Dearborn 28
Jinan 27
Rome 27
Hebei 26
Singapore 26
Beijing 25
Boardman 25
Shenyang 25
Nanchang 23
Brussels 19
Tianjin 15
Changsha 14
Florence 14
Ludwigshafen am Rhein 14
Seongnam 14
Falls Church 13
Verona 13
Auburn Hills 12
Kumar 12
London 12
Springfield 12
Grassobbio 11
Jiaxing 11
Hangzhou 9
Los Angeles 9
San Mateo 9
Turin 9
Izmir 8
Venice 8
Zhengzhou 8
Bologna 7
Ningbo 7
Phoenix 7
San Paolo di Civitate 7
Taizhou 7
Tehran 7
Dallas 6
Prilep 6
Prineville 6
San Pietro Vernotico 6
Bremen 5
Chicago 5
Lanzhou 5
Napoli 5
Ottawa 5
Reggio Emilia 5
Torino 5
Amsterdam 4
Castelnuovo Val Di Cecina 4
Catania 4
Central 4
Düsseldorf 4
Frankfurt am Main 4
Fuzhou 4
Guangzhou 4
Helsinki 4
Latina 4
Messina 4
Modena 4
Naples 4
Redwood City 4
Saint Petersburg 4
Taiyuan 4
Viareggio 4
Ancona 3
Battaglia Terme 3
Buccinasco 3
Clearwater 3
Cornaredo 3
Formia 3
Hefei 3
Introdacqua 3
Kiev 3
Kunming 3
Marentino 3
Padova 3
Pune 3
Shanghai 3
Totale 3.738
Nome #
Obesità e rischio cardiovascolare. 494
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: a 24 week randomized controlled double-dummy trial. 169
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 159
May Adiponectin be considered as a Novel Cardiometabolic Biomarker? 143
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 142
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease. 139
Visceral obesity and metabolic syndrome: two faces of the same medal? 137
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 134
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. 132
Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk 132
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. 131
Take the wind out your salis: relationship among energy drink abuse, hypertension, and break-up of cerebral aneurysm 131
The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects 131
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 129
Genetics and gene therapy of anderson-fabry disease 129
Association between low education and higher global cardiovascular risk 125
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 125
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. 123
Hemostatic function in young subjects with central obesity: relationship with left ventricular function 122
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 117
L’obesità fattore o co-fattore di rischio? 112
IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine. 112
Education and hypertension: impact on global cardiovascular risk 109
Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1. 107
Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. 106
Obesity and cardiovascular risk: the new public health problem of worldwide proportions. 101
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens 101
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRASFORMING GROWTH FACTOR BETA-1 95
Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial 95
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 93
Prevalence of obesity and ischaemic heart disease in hypertensive subjects 87
Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients 85
Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 79
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 79
Obesity: a main factor of metabolic syndrome? 76
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. 69
Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage. 68
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial 66
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 66
Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 65
Sindrome Metabolica 62
Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno renale 60
Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. 59
La terapia dietetica nell’insufficienza renale cronica. 57
Nutrizione,sovrappeso e sindrome metabolica 56
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure 56
Pathogenesis and molecular mechanisms of anderson–fabry disease and possible new molecular addressed therapeutic strategies 54
Scompenso cardiaco da disfunzione diastolica. 52
null 51
A case of infective colitis due to Yersinia enterocolitica complicated by microliver abscesses mimicking multiple liver occult metastases: a case report 49
Sindrome metabolica: fatti e compromessi. 48
Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction 46
Iperuricemia: significato clinico e nuove prospettive di trattamento 42
Metabolic memory in diabetic foot syndrome (dfs): epigenetic changes of the expression of micro-rnas and single nucleotide polymorphisms (snps) frequency in a cohort of diabetic patients with and without foot ulceration and correlation with indices of endothelial and adipo-inflammatory dysfunction 32
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators 32
Il paziente iperteso ad alto rischio cadiovascolare 30
Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage 22
Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis 22
Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial 14
Transforming growth factor β1 T29C gene polymorphism and hypertension: Relationship with cardiovascular and renal damage 12
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 10
Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides 6
Totale 5.687
Categoria #
all - tutte 21.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.260 137 50 86 132 133 152 135 72 133 47 128 55
2020/2021755 32 74 45 63 64 24 73 45 107 70 92 66
2021/2022733 28 129 16 30 68 27 40 48 78 91 44 134
2022/20231.053 87 168 36 108 102 154 75 79 146 13 44 41
2023/2024487 27 61 21 39 39 99 42 33 8 18 17 83
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 5.687